We would love to hear your thoughts about our site and services, please take our survey here.
Apologies if this has already been mentioned but Telegraph has an article in the Health section on Eroxon. "The gel that fixed my erectile dysfunction'. "It worked for me pretty much straight away and worked every time" according to 'David'. Better than a full page ad!
Hard to get my head round that the fact that the bid price is the same as the price in May 2022 and since then (September) Built has been sold to reduce debt to a manageable amount and results in January were in line with expectations. It seems strange to entertain a bid as this level given the oil price incentive for more exploration and the valuation of companies like Schlumberger.
Agree - I am just above my average now and wondering what to do - buy, sell or hold. I am convinced that the youth of today can't be bothered to cook or walk 5 minutes down the road, but then again I suspect there are 1 too many players in the market.
The running of this fund into the ground has made me determined not to ever invest in any Schroder fund again.
Barclays have had a price of 60p on Tullow for years and recently it's 85p. That encourages people to lose money on this mismanaged company more than a low rating.
The New all time low just got lower. I'm coming to the rapid conclusion it's not worth buying these small companies with great potential (including Versarien). So few of them seem to succeed. I would be better off becoming a problem gambler - I want some politician to stand up in parliament and declare that investors should be protected from unscrupulous small companies (with CEOs that pay themselves too much).
Not ex-dividend and no RNS! Any ideas?
Yes, certainly a big drop today - Lookers posted a small rise.
Quickly read the RNS and thought 'this is all pretty good' - so why the share price fall. Then read the Alliance News headline about the loss widening - had to then re-read RNS to find mention of that - well hidden - nice!
So the CEO Ian is 'delighted' - but losses increase and the share price has tanked. Strangely I'm not delighted with the way costs seem to be out of control and with the phrasing of the RNS where it is hard to decipher whether revenue is up or down.
Yes looks pretty good - no RNS here but results can be seen on Kenmare website
Unless we start getting boycotts/restrictions on Chinese goods, the tie in with BYD could prove a good move. Their cars are surely going to eat into Tesla sales. Even without this, the share price seem cheap and so I have bought some.
Bought some more on the news here. You have to remember this isn't just about the (gloomy) situation in the UK.
On the whole looks positive if not stunning, bought some more on the drop. Interestingly the headline news on this site is 'TP ICAP full-year profits boosted by market volatility' , The clue is in the last word of which there will be plenty more.
Is the chair Diane Savory involved in the company or just on the payroll? A bit of clarification would be nice - even the words 'with immediate effect'' or 'for personal reasons' or 'due to stress' would be useful. To raise 1.85m in December and then to appear to call it a day takes the biscuit.